Mar 11, 2021 / 09:30PM GMT
Presentations from AD/PD 2021
Mar 11, 2021 / 09:30PM GMT
=====================
Corporate Participants
=====================
* Ellen Rose
Prothena Corporation plc - Head of Communications
* Gene G. Kinney
Prothena Corporation plc - President, CEO & Director
* Philip Dolan
* Radhika Tripuraneni
Prothena Corporation plc - Chief Development Officer
* Tran B. Nguyen
Prothena Corporation plc - CFO & COO
* Wagner M. Zago
Prothena Corporation plc - Chief Scientific Officer
=====================
Conference Call Participants
=====================
* Charles Cliff Duncan
Cantor Fitzgerald & Co., Research Division - Senior Analyst
* Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
* Kennen B. MacKay
RBC Capital Markets, Research Division - MD & Co-Head of US Biotechnology Research
* Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
* Robert Cummins Hazlett
Prothena Corp PLC
(FRA:0PT)
€
6.83
-0.51 (-6.9%)
Market Cap: 368.69 Mil
Enterprise Value: 89.42 Mil
PE Ratio: 0
PB Ratio: 1.38
GF Score: 74/100 Prothena Corporation PLC to Review Oral Presentations from AD/PD 2021 Transcript
Mar 11, 2021 / 09:30PM GMT
Release Date Price:
€19.1
(+6.70%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot